Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is
commencing today, through a subsidiary, a cash tender offer to purchase
all outstanding shares of common stock of Idenix Pharmaceuticals, Inc.
(NASDAQ:IDIX). On June 09, 2014, Merck announced its intent to acquire
Idenix.
Language:
English
Contact:
Media:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461Investors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more